HMGB1 and bacterial infectious disease with sepsis: Pharmacological agents with anti-inflammatory properties, such as calycosin (72) and propofol (89), have been shown to mitigate sepsis-induced AEC injury by inhibiting HMGB1-mediated activation of downstream inflammasomes and signaling pathways, thereby alleviating bacterial Sepsis-Associated ALI.